---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-041230"
form_type: "8-K"
ticker: null
cik: "0000727207"
company_name: "Accelerate Diagnostics, Inc"
filed_at: "2024-03-29T23:59:59+00:00"
generated_at: "2026-06-04T05:37:22.845470+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Accelerate Diagnostics reports Q4 net loss $13M, full-year net loss $61.6M; Wave trials planned Q2 2024

## Summary
- Q4 net sales $3.0M flat YoY; full-year net sales $12.1M down 5% from $12.8M.
- Q4 gross margin 21% vs 28% YoY; full-year 21% vs 26%, including $1.2M inventory write-down.
- Q4 net loss $13.0M ($0.89/share); full-year net loss $61.6M ($4.94/share).
- Cash used Q4 $7.9M, full-year $46.3M; year-end cash $13.2M.
- Wave AST system clinical trials on track for Q2 2024; ~90% customer interest in adoption.

## SEC filing metadata
- accession: 0001104659-24-041230
- form_type: 8-K
- cik: 0000727207
- company_name: Accelerate Diagnostics, Inc
- filed_at: 2024-03-29T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/727207/000110465924041230/0001104659-24-041230-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/727207/000110465924041230/tm2410254d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-041230
- JSON: https://secwatch.observer/filing/0001104659-24-041230.json
- Plain text: https://secwatch.observer/filing/0001104659-24-041230.txt

## Key facts
- Earnings Releases
  Accelerate Diagnostics, Inc reported financial results for the quarter and full-year ending December 31, 2023.
  - Period: the quarter and full-year ending December 31, 2023
  - Result: reported results
  source text: On March 28, 2024, Accelerate Diagnostics, Inc. (the “Company”) issued a press release announcing its financial results for the quarter and full-year ending December 31, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/727207/000110465924041230/0001104659-24-041230-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.